Patent · US Expired

Compounds and method for inhibiting MRP1

US6670373B1 · kind B1 · utility

12Cited by
3References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2002
Grant dateDec 30, 2003
Priority date
Expiry dateJul 2, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula (I), which is useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.